Loading...
Noile-Immune Biotech Inc.
4893.T•JPX
Healthcare
Biotechnology
¥172.00
¥-2.00(-1.15%)
Noile-Immune Biotech Inc. (4893.T) Financial Performance & Income Statement Overview
Review Noile-Immune Biotech Inc. (4893.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-97.61%
↓ 97.61%
Operating Income Growth
-37.89%
↓ 37.89%
Net Income Growth
14.65%
↑ 14.65%
Operating Cash Flow Growth
-1.69%
↓ 1.69%
Operating Margin
-13610.91%
↓ 13610.91%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-12103.05%
↓ 12103.05%
ROE
-18.09%
↓ 18.09%
ROIC
-21.65%
↓ 21.65%
Noile-Immune Biotech Inc. (4893.T) Income Statement & Financial Overview
Analyze Noile-Immune Biotech Inc.’s 4893.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.00M | $3.00M | $0.00 | $2.59M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $195000.00 |
| Gross Profit | $2.00M | $3.00M | $0.00 | $2.39M |
| Gross Profit Ratio | $1.00 | $1.00 | $0.00 | $0.92 |
| R&D Expenses | $66.00M | $90.00M | $228.84M | $194.32M |
| SG&A Expenses | $113.00M | $123.00M | $113.69M | $147.35M |
| Operating Expenses | $179.00M | $214.00M | $342.53M | $341.68M |
| Total Costs & Expenses | $179.00M | $214.00M | $342.53M | $341.87M |
| Interest Income | $0.00 | $0.00 | $49000.00 | $28000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $177.00M | $210.00M | $0.00 | $1000.00 |
| EBITDA | $0.00 | $0.00 | -$342.53M | -$339.57M |
| EBITDA Ratio | $0.00 | $0.00 | -$131.26 | |
| Operating Income | -$177.00M | -$211.00M | -$342.53M | -$339.29M |
| Operating Income Ratio | -$88.50 | -$70.33 | -$131.15 | |
| Other Income/Expenses (Net) | $1.00M | $107.00M | -$107000.00 | -$282000.00 |
| Income Before Tax | -$176.00M | -$104.00M | -$342.64M | -$339.57M |
| Income Before Tax Ratio | -$88.00 | -$34.67 | -$131.26 | |
| Income Tax Expense | $1.00M | $0.00 | $605000.00 | $609000.00 |
| Net Income | -$177.00M | -$104.00M | -$343.24M | -$340.18M |
| Net Income Ratio | -$88.50 | -$34.67 | -$131.49 | |
| EPS | -$4.09 | -$2.40 | -$7.93 | -$7.86 |
| Diluted EPS | -$4.09 | -$2.40 | -$7.93 | -$7.86 |
| Weighted Avg Shares Outstanding | $43.30M | $43.30M | $43.30M | $43.28M |
| Weighted Avg Shares Outstanding (Diluted) | $43.30M | $43.30M | $43.30M | $43.28M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan